Delivery Order SPE2DB24D6044-SPE2DB25FLHFJ

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,946.55 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1%-EPI 1:200,000 10ML, a local anesthetic medication. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,686.11, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 IDC that runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,491.66 firm fixed-price delivery order contract is for the supply of XYLOCAINE 1%-EPI 1:100,000 10ML, a local anesthetic medication. The contract has an ultimate completion date of March 7, 2024 and was awarded on March 6, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,769.25 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1%-EPI 1:200,000 30ML, a local anesthetic medication, with an ultimate completion date of April 21, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a local anesthetic medication. The $3,635.91 Firm Fixed Price contract is a Delivery Order that has an ultimate completion date of April 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the delivery of Xylocaine 1%-EPI 1:100,000 50ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price of $2,775.00 and an ultimate completion date of July 31, 2024. The award was made on July 30, 2024 and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of XYLOCAINE 1%-EPI 1:100,000 20ML, a specialty pharmaceutical product, at a firm fixed price of $1,203.31. The contract has a completion date of February 14, 2024 and was awarded on February 13, 2024. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.66 firm fixed-price delivery order is for the supply of Xylocaine 1%-Epi 1:100,000 10ML, a local anesthetic medication. The award was made on August 11, 2022, with a completion date of August 12, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which is a Delivery Order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), is for the supply of XYLOCAINE 2%-EPI 1:200,000 20ML, a local anesthetic medication. The award has a ceiling value of $1,811.28 and an ultimate completion date of July 19, 2024. The contract is a Firm Fixed Price arrangement. There is no...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,027.93, is for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D6044
    Indefinite Delivery Contract
  • SPE2DB24D6044-SPE2DB25FLHFJ
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,009.20 fixed-price delivery order is for XYLOCAINE 2%-EPI 1:200,000 20ML, a specialty medication. The contract has an ultimate completion date of January 7, 2025.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is a task order issued under that larger IDC contract. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 4/7/25, 9:49 AM